|Bid||91.51 x 800|
|Ask||99.78 x 2200|
|Day's Range||93.11 - 94.76|
|52 Week Range||76.41 - 100.15|
|Beta (3Y Monthly)||0.66|
|PE Ratio (TTM)||58.80|
|Earnings Date||Feb 19, 2019|
|Forward Dividend & Yield||2.00 (2.12%)|
|1y Target Est||104.32|
Who Is Eyeing Medtronic Now? Medtronic’s (MDT) Spine Therapies generated revenues of $1.3 billion in the first half of fiscal 2019. Medtronic’s (MDT) Brain Therapies generated revenues of $1.2 billion in the first half of fiscal 2019, reflecting ~11% YoY growth.
Medtronic’s (MDT) Minimally Invasive Therapies Group (or MITG) consists of the Surgical Innovations (or SI), and Respiratory, Gastrointestinal & Renal (or RGR) segments.
Medtronic’s Cardiac & Vascular Group consists of the Cardiac Rhythm & Heart Failure (or CRHF), the Coronary & Structural Heart (or CSH), and Aortic, Peripheral & Venous (or APV) segments.
Medtronic’s (MDT) Cardiac & Vascular Group generated revenues of $2.9 billion in the second quarter of fiscal 2019 compared to $2.8 billion in the second quarter of fiscal 2018, reflecting ~3% YoY growth.
Medtronic (MDT) reported net income of $1.1 billion in the second quarter of fiscal 2019 compared to $2.0 billion in the second quarter of fiscal 2018. Medtronic’s net income in the first half of fiscal 2019 totaled $2.2 billion compared to $3.0 billion in the same period the prior year. Wall Street analysts anticipate that Medtronic is expected to report net income of $1.25 billion in the third quarter of fiscal 2019.
Medtronic (MDT) reported net revenues of $7.5 billion in the second quarter of fiscal 2019 compared to $7.1 billion in the second quarter of fiscal 2018, reflecting 6% YoY growth.
In November, Medtronic announced that the company would acquire Nutrino Health, a company that specializes in nutrition associated data services, analytics, and technologies. Medtronic’s diabetes segment is expected to improve significantly with the acquisition of Nutrino Health. The acquisition of Nutrino Health will bring together Nutrino Health’s robust food database, expertise in nutrition science and food analysis systems, and Medtronic’s innovative diabetes management resources.
December 10, 2018 - Medtronic plc (MDT), the global leader in medical technology, today announced it has been named one of America`s Most JUST Companies in 2018, according to Forbes magazine and JUST Capital, a nonprofit that ranks publicly-traded corporations on the issues Americans care about most. Medtronic was ranked 61st on this year`s JUST 100: America`s Best Corporate Citizens list for outperforming its peers in areas such as fair treatment of employees, job creation, customer treatment, and product quality. To determine the ranking, Forbes and JUST Capital surveyed more than 81,000 Americans over four years and asked what people prioritize most regarding corporate behavior today.
Insulet Corporation (PODD) continues to expand Omnipod's market access on growing reimbursements. The company operates in a highly competitive environment.
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]
BRAMPTON, ON , Dec. 7, 2018 /CNW/ - Medtronic of Canada Ltd., an indirect subsidiary of Medtronic plc (MDT) announced today that it has been recognized as one of the Greater Toronto's Top Employers for 2019. Medtronic's philanthropic and employee-led activities, along with a top tier benefits package, are among some of the many reasons Medtronic is considered a top employer. The Medtronic Mission is another reason why people join and stay at Medtronic.
NEW YORK, Dec. 07, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
December 7, 2018 - The board of directors of Medtronic plc (MDT) today approved the fiscal year 2019 third quarter cash dividend of $0.50 per ordinary share, representing a 9 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June 2018. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 41 consecutive years.
Do shareholders automatically get shares in the new company? Or cash? Or does one need to actively do something to make it all happen?
If you are looking for the best ideas for your portfolio you may want to consider some of Jeffrey Talpins’ third quarter top stock picks. For those of you who never heard of Jeffrey Talpins, we’ll provide some basic background. He is the founder and portfolio manager of one of the biggest hedge funds that […]
Medtronic Plc said on Tuesday it would pay $50.9 million to resolve U.S. Justice Department probes into how companies it later acquired marketed medical devices, including one meant to treat a vascular defect in the brain. As part of the accord, ev3 Inc, which Medtronic now owns, will pay $17.9 million and plead guilty to a charge related to its marketing of a neurovascular medical device for unproven and potentially dangerous uses, federal prosecutors in Boston said. The misdemeanor charge relates to the Onyx Liquid Embolic System, which the U.S. Food and Drug Administration in 2005 approved for the limited use of blocking blood flow to arteriovenous malformations in the brain.
December 4, 2018 - Medtronic (MDT) is notifying customers worldwide of a voluntary field corrective action for its Puritan Bennett(TM) 980 (PB980) ventilator series. Medtronic initiated this field action on September 19, 2018. A Puritan Bennett 980 ventilator is a mechanical ventilator used to support a patient`s breathing. The voluntary field corrective action is a software update to address customer feedback.
Surgical robots are increasingly being placed in hospital operating rooms. AlphaCentric Global Innovation's portfolio manager names a few investment opportunities in this fast-growing space.
AI is the buzzword these days, and the market has huge growth potential. PR Newswire, citing QY Research, reported that the global AI market could grow 52.6% (compounded annually) from $2.65 billion in 2017 to $78 billion by 2025. IBM (IBM) has been the largest player in the AI market.
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We’ll look at Medtronic plc’s (NYSE:MDT) P/E ratio and reflect on Read More...